• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Entresto numbers

anonymous

Guest
Help me out: was it at realignment time in May that the Entresto goals were jacked up and suddenly we are a slipping lower and lower? Help me with the timeline, please.
 

<